4.2 Review

Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

The orphan receptor GPR55 is a novel cannabinoid receptor

E. Ryberg et al.

BRITISH JOURNAL OF PHARMACOLOGY (2007)

Article Pharmacology & Pharmacy

Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies

Belen Ferrer et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2007)

Review Neurosciences

The acute effects of cannabinoids on memory in humans: a review

Mohini Ranganathan et al.

PSYCHOPHARMACOLOGY (2006)

Article Clinical Neurology

Cannabidiol monotherapy for treatment-resistant schizophrenia

Antonio Waldo Zuardi et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2006)

Article Neurosciences

Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice

LE Long et al.

NEUROPSYCHOPHARMACOLOGY (2006)

Article Behavioral Sciences

The effect of Δ9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats

DT Malone et al.

BEHAVIOURAL BRAIN RESEARCH (2006)

Article Medicine, General & Internal

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

JP Despres et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Biochemistry & Molecular Biology

Agonistic properties of cannabidiol at 5-HT1a receptors

EB Russo et al.

NEUROCHEMICAL RESEARCH (2005)

Review Psychiatry

Mismatch negativity in schizophrenia: a meta-analysis

D Umbricht et al.

SCHIZOPHRENIA RESEARCH (2005)

Article Pharmacology & Pharmacy

Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice

FA Moreira et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2005)

Article Behavioral Sciences

Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists

NR Swerdlow et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)

Article Behavioral Sciences

The effect of SR 141716 and apomorphine on sensorimotor gating in Swiss mice

DT Malone et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)

Article Substance Abuse

Cannabis use and psychotic disorders: an update

W Hall et al.

DRUG AND ALCOHOL REVIEW (2004)

Article Medicine, Research & Experimental

Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum

VMC Guimaraes et al.

LIFE SCIENCES (2004)

Review Clinical Neurology

Cannabis-associated psychosis - Current status of research

FM Leweke et al.

CNS DRUGS (2004)

Article Neurosciences

Cannabinoid-induced Fos expression within A10 doparninergic neurons

S Patel et al.

BRAIN RESEARCH (2003)

Article Pharmacology & Pharmacy

Cannabidiol: An overview of some pharmacological aspects

R Mechoulam et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2002)

Article Biochemistry & Molecular Biology

Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice

K Monory et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)

Article Psychiatry

Reduced binocular depth inversion in schizophrenic patients

U Schneider et al.

SCHIZOPHRENIA RESEARCH (2002)

Review Neurosciences

A systems model of altered consciousness: Integrating natural and drug-induced psychoses

FX Vollenweider et al.

BRAIN RESEARCH BULLETIN (2001)

Article Neurosciences

Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation

M Pistis et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2001)

Article Psychiatry

Diagnosing schizophrenia in the initial prodromal phase

J Klosterkötter et al.

ARCHIVES OF GENERAL PSYCHIATRY (2001)

Article Psychiatry

Psychiatric effects of cannabis

A Johns

BRITISH JOURNAL OF PSYCHIATRY (2001)

Review Medicine, Research & Experimental

Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia

S Kapur et al.

ANNUAL REVIEW OF MEDICINE (2001)

Review Behavioral Sciences

Pharmacological and molecular targets in the search for novel antipsychotics

B Scatton et al.

BEHAVIOURAL PHARMACOLOGY (2000)

Article Behavioral Sciences

Different effects of nabilone and cannabidiol on binocular depth inversion in man

FM Leweke et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)

Review Neurosciences

To model a psychiatric disorder in animals: Schizophrenia as a reality test

BK Lipska et al.

NEUROPSYCHOPHARMACOLOGY (2000)